Share Price 966.8: Mar 03,2023 . Key financial ratios for pharmaceutical companies are those related to R&D costs and the company's ability to manage high levels of debtand profitability. Pharmaceutical companies have been top performers in the healthcare sector in an era of aging populations, rising healthcare costs, and the ongoing development of new and extremely profitable medicines. Lincoln Pharmaceuticals 5. The quick ratio is a financial metric used to measure short-term liquidity. Do you want to find out the Price to Sales (PS) ratio history of SUN PHARMACEUTICAL INDUSTRIES and compare it with industry peers of SUN PHARMACEUTICAL INDUSTRIES . Discover the right bonds meeting your investment amount & investment horizon, Fundamental, Stock Ideas, Multibaggers & Insights, Stock & Index F&O Trading Calls & Market Analysis, Commodity Trading Calls & Market Analysis, Currency Derivatives Trading Calls & Insights, Options Trading Advice and Market Analysis, Model portfolios, Investment Ideas, Guru Screens and Much More, Proprietary system driven Rule Based Trading calls, Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas, Details stock report and investment recommendation, 15-20 High Growth Stocks primed for price jumps, +272.45 (+1.57%) Calculation: Current Assets / Current Liabilities. More about current ratio. Today, its headquarters are located in Basel. The accounts receivables turnover ratio helps determine such lapses and directs the company towards a healthy accounting system with respect to its customers. The United States continues to be the leading market for pharmaceuticals globally, followed by other emerging markets. Browse . Browse . White Lightning Ruston, La, The expected growth of the global pharmaceuticals market in 2020 is $1228.45 billion, with 2021 reaching $1250.24 billion. Once a pharmaceutical company manages to bring a product to market, a key element is howthe company can manufacture and sell the product. These ratios are derived by dividing one financial measurement by the other. The curation of data over 10 years makes it a go-to document for in-depth industry trends. Over 233 treatments are currently under consideration, and 161 vaccines are in development as of June 2020. Compare PFE With Other Stocks. This turnover ratio helps determine the relationship between the funds used by the company and the revenue generated with it. A further 70 cents is being produced in Latin America for every dollar made by the pharmaceutical industry. The United States was the largest single pharmaceutical market in 2021, with more than 550 billion U.S. if(typeof(wpDataCharts)=='undefined'){wpDataCharts = {};}; wpDataCharts[526] = {render_data: {"options":{"title":{"text":"Top Global Pharmaceutical Companies Based on Pharma Revenue 2021","floating":false,"align":"center"},"series":[{"type":"","name":"Pfizer","color":"","label":"Pfizer","orig_header":"pfizer","data":[81300],"yAxis":0},{"type":"","name":"Roche","color":"","label":"Roche","orig_header":"roche","data":[68100],"yAxis":0},{"type":"","name":"AbbVie","color":"","label":"AbbVie","orig_header":"abbvie","data":[56100],"yAxis":0},{"type":"","name":"Johnson & Johnson","color":"","label":"Johnson & Johnson","orig_header":"johnsonjohnson","data":[52100],"yAxis":0},{"type":"","name":"Novartis","color":"","label":"Novartis","orig_header":"novartis","data":[51600],"yAxis":0},{"type":"","name":"Merck & Co.","color":"","label":"Merck & Co.","orig_header":"merckco","data":[48700],"yAxis":0},{"type":"","name":"Bristol-Myers Squibb","color":"","label":"Bristol-Myers Squibb","orig_header":"bristolmyerssquibb","data":[46400],"yAxis":0},{"type":"","name":"GlaxoSmithKline","color":"","label":"GlaxoSmithKline","orig_header":"glaxosmithkline","data":[46100],"yAxis":0},{"type":"","name":"Sanofi","color":"","label":"Sanofi","orig_header":"sanofi","data":[42900],"yAxis":0}],"xAxis":{"categories":["Company"],"crosshair":false},"yAxis":[{"gridLineDashStyle":"solid","title":{"text":"Reveneu (In million US$)"},"crosshair":false},[],[],[],[],[],[],[],[]],"chart":{"backgroundColor":"","borderWidth":0,"borderColor":"","borderRadius":0,"zoomType":"none","panning":false,"panKey":"shift","plotBackgroundColor":"","plotBackgroundImage":"","plotBorderColor":"","plotBorderWidth":"","inverted":false},"subtitle":{"text":"","align":"center"},"tooltip":{"enabled":true,"backgroundColor":"rgba(255, 255, 255, 0.85)","borderWidth":"1","borderColor":"","borderRadius":3,"shared":false,"valuePrefix":"","valueSuffix":""},"legend":{"enabled":true,"backgroundColor":"","title":{"text":""},"layout":"horizontal","align":"center","verticalAlign":"bottom","borderWidth":"0","borderColor":"","borderRadius":"0"},"exporting":{"enabled":false,"chartOptions":{"plotOptions":{"series":{"dataLabels":{"enabled":false}}}},"filename":"","width":"","buttons":{"contextButton":{"align":"right","verticalAlign":"top","symbolStroke":"#666","text":""}}},"credits":{"enabled":true,"href":"https:\/\/market.us\/","text":"\u00a9 Market.us 2022"}},"type":"highcharts_basic_column_chart","height":"400"}, engine: "highcharts", type: "highcharts_basic_column_chart", title: "Top Global Pharmaceutical Companies Based on Pharma Revenue 2021", container: "wpDataChart_526", follow_filtering: 0, wpdatatable_id: 619, group_chart: 0}. A higher FAT ratio indicates that the management has efficiently used its fixed assets to generate revenue for the company while a lower FAT ratio points at the opposite. Key Financial Ratios for Airline Companies. 3 Year Return: 16.4% 5 Year Return: 12.38% INVEST NOW Equity Funds PARTNERED BY UTI Mastershare Unit Scheme - Direct Plan (G) 3 Year Return: 14.8% 5 Year Return: 11.18% INVEST NOW Equity Funds. . The market capitalization of the pharmaceutical and consumer goods company is $428.7 million. ROI. Johnson & Johnson is a leader in medical device products, research and development, pharmaceutical manufacturing, and consumer level. Lincoln Pharmaceuticals 5. The current ratio is an essential financial matric that helps to understand the liquidity structure of the business. On the trailing twelve months basis Current Liabilities decreased faster than Industry's Current Assets, this led to improvement in Industry's Working Capital Ratio to 1.77 in the 3 Q 2019, Working Capital Ratio remained below Major Pharmaceutical Preparations Industry average. transverse baby 28 weeks uncomfortable. Through this study, we have tried to compare and analyse the following 3 ratios for 5 pharmaceutical companies vis--vis the industry average for these ratios. Company Name, Ticker, Competitors, else.. Net Income/Employee Price/Book(PB) Ratio of SUN PHARMACEUTICAL INDUSTRIES - 03 Mar,2023 SUN PHARMACEUTICAL INDUSTRIES Price/Earnings(PE) Ratio-03 Mar,2023 2023Gospel Vision. Bayer is the 4th most profitable pharmaceutical company globally. October 12, 2020 The annual growth rate has a CAGR of 1.8%. Also known as the times-interest-earned ratio, this is used by lenders, creditors, and investors to gauge the risk factor involved in lending capital to the company. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Not solely Johnson & Johnson, but the entire industry will grow, based on This essay sample on Pharmaceutical Industry Average Financial Ratios 2018 provides all necessary basic info on this matter, including the most common for and against arguments. It is calculated as the sum of current assets minus inventories, divided by current liabilities. More about debt-to-equity ratio. This cookie is set by GDPR Cookie Consent plugin. More about current ratio . Home > PS Ratio > SUN PHARMACEUTICAL INDUSTRIES . 2020 brought drastic changes to every industry, and the pharmaceutical one isnt an exception current issues in pharmacy 2021 are closely associated with the pandemic and its results. Number of U.S. listed companies included in the calculation: 4190 (year 2021). Pharmaceutical industry is currently one of the most fast-developing ones. Standard Medical Pharmaceuticals Key Financial Ratios, Standard Medical This will give the average number of days your customer takes to pay their debts. Note, Numbers include only companies who have reported earnings results. The Asia Pacific is the third-largest market for pharmaceuticals globally, after North America and Europe. Calculation: Current Assets / Current Liabilities. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. french open tsitsipas woolworths shareholder equity. Current and historical current ratio for Teva Pharmaceutical Industries (TEVA) from 2010 to 2022. Understanding Key Financial Ratios and Pharmaceutical Stocks, Price-to-Book (PB) Ratio: Meaning, Formula, and Example, Fixed Asset Turnover Ratio Explained With Examples, Understanding Liquidity Ratios: Types and Their Importance. % Off. Therefore, how efficiently they employ the capital that equity investors provide is indeed a key indicator of the effectiveness of the company's management and of the company's ultimate profitability. ), Book Value [InclRevalReserve]/Share (Rs. Net credit purchases may be substituted at times by COGS and, Average accounts payable = sum of accounts payable at the beginning and end of accounting period / 2. A company's ROE is a valuable indicator of both how effectively the organization is utilizing its equity capital and how profitable the company is for equity investors. Sunpharma has recorded thei highest current ratio in 2011. Share Price 958.9: Mar 01,2023 . Vivimed Labs 2. incurred by the company and what percentage of this is to the total sales. Current ratio, and 3. Current Industry PE. In other words, this ratio is a measure of how well a company is generating sales from its inventory. The current CPI index for 2011 uses expenditure data collected for the 2-year period from 20072008. Integration of the many financial tools on the web. , The price-to-research ratio measures the relationship between a company's market capitalization and its research and development expenses. Roche was established in 1896. However, at times, a higher inventory ratio could also cause loss of sales as there is no inventory left to sell. ROI. But opting out of some of these cookies may affect your browsing experience. J.B. Maverick is an active trader, commodity futures broker, and stock market analyst 17+ years of experience, in addition to 10+ years of experience as a finance writer and book editor. In depth view into Teva Pharmaceutical Industries Current Ratio explanation, calculation, historical data and more Current business dynamics indicate that innovation will continue to drive growth in the 2022 pharma market. Research Tutorial; Current Industrial Reports. solitude parking camera. The pharma industry must embrace new technologies, patient design, and innovations. Hoffmann-La Roche, an international Swiss multinational healthcare company, operates worldwide under two divisions Pharmaceuticals & Diagnostics. Global revenues from the pharmaceutical industry total 1.2 trillion dollars. ideal current ratio for pharmaceutical industry | "Trailing and forward price to earnings ratio (PE ratio) in the health & pharmaceuticals sector in Western Europe 2022, by industry." However, there is no reference score or range for FAT ratio. Kpmg Sponsored Degree, A value of 1 indicates a normal quick ratio. Once a pharma product reaches the marketplace, the company must determine how high a price the company can charge for a drug to earn a profitable return on its investment in the shortest amount of time. Built using WordPress and the Highlight Theme. . Once a pharmaceutical company manages to bring a product to market, a key element is how the company can manufacture and sell the product. However, you may visit "Cookie Settings" to provide a controlled consent. The pharmaceutical industrys characteristics vary from one region to the next. The quick ratio is a good indicator of a company's ability to effectively cover its day-to-day operating expenses. Key financial ratios for pharmaceutical companies are those related to R&D costs and the company's ability to manage high levels of debt and profitability. To make informed choices, investors need to consider the key financial ratios that are most helpful in the analysis and equity evaluation of pharma firms. | .a{fill:#6db41e;stroke:#637733;}.b,.d{fill:none;}.b{stroke:#fff;}.c{stroke:none;}, BSE: 511042 | NSE: | Major Pharmaceutical Preparations Industry. Industry: 2834- Pharmaceutical Preparations Measure of center: Financial ratio Year Year Year Year 2020 2019 2018 2017 2016 Debt ratio 0.34 0.40 0.43 0.47 Debt-to-equity ratio 0.27 0.36 0.32 0.30 18 more rows The paper was updated on November 2, 2021. This report advises NVS to pursue more market acquisition strategies in emerging markets. Learn more about our online cap table and our 409a valuation services. Eqvista does not provide legal, financial or tax advice. UK)","Africa","Middle East","Southeast & East Asia","China","EU","North America","Oceania","Japan"],"crosshair":false},"yAxis":[{"gridLineDashStyle":"solid","title":{"text":"Market Growth in %"},"crosshair":false}],"chart":{"backgroundColor":"","borderWidth":0,"borderColor":"","borderRadius":0,"zoomType":"none","panning":false,"panKey":"shift","plotBackgroundColor":"","plotBackgroundImage":"","plotBorderColor":"","plotBorderWidth":"","inverted":false},"subtitle":{"text":"","align":"center"},"tooltip":{"enabled":true,"backgroundColor":"rgba(255, 255, 255, 0.85)","borderWidth":"1","borderColor":"","borderRadius":3,"shared":false,"valuePrefix":"","valueSuffix":""},"legend":{"enabled":true,"backgroundColor":"","title":{"text":""},"layout":"horizontal","align":"center","verticalAlign":"bottom","borderWidth":"0","borderColor":"","borderRadius":"0"},"exporting":{"enabled":false,"chartOptions":{"plotOptions":{"series":{"dataLabels":{"enabled":false}}}},"filename":"","width":"","buttons":{"contextButton":{"align":"right","verticalAlign":"top","symbolStroke":"#666","text":""}}},"credits":{"enabled":true,"href":"https:\/\/market.us\/","text":"\u00a9 Market.us 2022"}},"type":"highcharts_basic_column_chart","height":"400"}, engine: "highcharts", type: "highcharts_basic_column_chart", title: "World Pharmaceutical Market Growth By Region 2021-2025", container: "wpDataChart_525", follow_filtering: 0, wpdatatable_id: 618, group_chart: 0}. This statistic lists the global pharmaceutical sales between 2010 and 2021. Within Healthcare sector 4 other industries have achieved higher Working Capital Ratio. ideal current ratio for pharmaceutical industry early childhood conferences 2022 florida mediacom tv everywhere roku . Browse . , Though a higher payable turnover ratio indicates the creditworthiness of a company, the company must strive towards favorable credit terms with their suppliers so that they do not have to make hurried and frequent payments, in which they run the risk of penalties. Inventories are those goods in stock of a company that it plans to sell. Keywords: DuPont's 3-point, DuPont's 5-point, financial ratios 1. Novartis, a Swiss corporation, generated 52 billion U.S. dollars in pharmaceutical revenue. For the Year ended 2019: Current Assets = Cash and Cash Equivalents + Marketable Securities + Accounts Receivable. The industry is trading at a PE ratio of 26.0x which is lower than its 3-year average PE of 46.5x. It is at the forefront of immunology, oncology, ophthalmology infectious diseases, and neuroscience. is jackpocket app legal in texas. A lower ratio indicates the contrary. The performance of a business is ultimately reflected in their periodic financial statements. Scores higher than 1 indicates good health of the companys debt scenario. All companies havent been maintaining ideal current ratio except Sunpharma. This ratio too does not have a range and needs to be compared with the companys previous ratios and those of similar businesses in the industry. Browse . Search Stocks. Further, to get the account receivables turnover in days, divide 365 by the accounts receivable turnover ratio. The rate at which a company replaces inventory through sales in a given period of time is indicated by the inventory turnover ratio. Startups are exploring the use of these technologies to address the various challenges in the pharma industry, such as automation and optimization of the manufacturing processes, as well as designing effective marketing and ROA. The size of the firm positively but moderately governs the solvency of the Indian pharmaceutical firms (Ali, 2020c). liability for the information given being complete or correct. Teva acquired Allergan's generics business Actavis Generics. A higher inventory turnover ratio is ideal as it indicates that sales are quick and there is a demand for the companys products as well. A higher ratio automatically indicates the companys strong financial position, attracting more investors. That being said, how good a current ratio is depends on the type of company youre talking about. Necessary cookies are absolutely essential for the website to function properly. . A lower DSI is optimal as it indicates lesser days required to convert inventory to sales. Pharmaceutical Preparations: industry financial ratios benchmarking This cookie is set by GDPR Cookie Consent plugin. Successfully managing debt obligations is a major factor in the long-term viability and profitability of any pharmaceutical company. The most important key figures provide you with a compact summary of the topic of "Global pharmaceutical industry" and take you straight to the corresponding statistics. Get in touch with us. The regions primary driver of the pharmaceutical industry is generics. The price-to-research ratio is calculated by dividing a company's market value by its last 12 months of expenditures on research and development. Current and historical current ratio for Teva Pharmaceutical Industries (TEVA) from 2010 to 2022. irritability crossword clue. This helps management spot problematic areas in the very early stages. Wycombe Vs Cambridge Results, Artificial Intelligence. In comparison, the quick ratio is far more conservative than the current ratio which accounts for only the current assets. As important as they are as a document, the numbers in these statements alone are not capable of indicating any underlying issues, risk trends, or a probable future performance, unless they are analyzed properly. This ratio also helps to compare various companies in the same sector. This score has to be compared with competitors and industry benchmarks to make good sense of it. Industry benchmarks are either derived from these company-driven multiples or from credible industry benchmark databases. Major Pharmaceutical Preparations Industry Efficiency, Revenue per Employee, Inventory and Receivable Turnover Ratios Q4 2022 At a Glance Growth Rates Profitability Valuation Financial Strength Efficiency Mgmt. If you have a Facebook or Twitter account, you can use it to log in to ReadyRatios: You can log in if you are registered at one of these services: This website uses cookies. ideal current ratio for pharmaceutical industry A score higher than 3 indicates that the company management is failing to use their current assets efficiently, not adopting the right strategies of financing, or failing to manage their working capital. The ratio is calculated by dividing the current year's gross profit by the previous year's total R&D expenditures. The interest coverage ratio is an indicator of the companys ability to pay interest on its outstanding debt. 05.10.2017. El Paso Saddlery Military, The digital revolution can be a boon for the pharmaceutical industry by using disruptive technology such as 3D printed drugs, artificial Intelligence guided therapies, and preventative medicine. The scope of growth in the mutual fund investment space is immense in . Current and historical current ratio for Pfizer (PFE) from 2010 to 2022. The best of the best: the portal for top lists & rankings: Strategy and business building for the data-driven economy: Pharmaceutical market: worldwide revenue 2001-2022, Global pharmaceutical market - revenue distribution 2010-2021, by region, Top therapeutic classes by global pharmaceutical sales 2018 estimates, Total global pharmaceutical R&D spending 2014-2028, Number of novel drugs approved annually by CDER 2008-2022, Revenue of the worldwide pharmaceutical market from 2001 to 2022 (in billion U.S. dollars), World pharmaceutical sales 2017-2021 by region, Global pharmaceutical sales from 2017 to 2021, by region* (in billion U.S. dollars), World pharmaceutical market distribution by submarket 2014-2021, Distribution of the total global pharmaceutical market sales from 2014 to 2021, by submarket*, Revenues of top 10 global pharmaceutical markets 2021, Revenues of top 10 national pharmaceutical markets worldwide in 2021 (in billion U.S. dollars), Top pharmaceutical products by sales worldwide 2021, Leading pharmaceutical products by sales worldwide in 2021 (in billion U.S. dollars), Share of pharmaceutical value worldwide 2021, by country, Value share of the pharmaceutical market worldwide as of November 2021, by country*, Value share of pharmaceutical subsectors worldwide 2003 vs. 2021, Value share of the pharmaceutical market worldwide in 2003 and 2021, by subsector*, Top therapy classes by spending global market 2026 forecast, Projected top therapy areas worldwide in 2026, by spending (in billion U.S. dollars), Global pharmaceutical revenue by technology 2012-2026, Global pharmaceutical revenue distributed by technology from 2012 to 2026 (in billion U.S. dollars), Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026, Prescription drugs sales worldwide excluding generics and orphan drugs from 2012 to 2026 (in billion U.S. dollars), Projection of global revenue for orphan prescription drugs 2012-2026, Global prescription orphan drug sales from 2012 to 2026 (in billion U.S. dollars), Worldwide generic prescription drug sales 2012-2026, Worldwide generic prescription drug sales from 2012 to 2026 (in billion U.S. dollars), Revenue of the global OTC pharmaceutical market 2016-2027, Revenue of the global OTC pharmaceutical market from 2016 to 2027 (in billion U.S. dollars), Global oncology spending from 2011 to 2023 (in billion U.S. dollars), Tota pharmaceutical value worldwide 2021, by subsector, Total pharmaceutical value worldwide as of November 2021, by subsector* (in million U.S. dollars), Top 50 pharmaceutical companies - Rx sales and R&D spending 2021, Leading 50 global pharmaceutical companies by prescription sales and R&D spending in 2021 (in billion U.S. dollars), Global Rx drug market share by top companies 2019 and 2026, Top 20 pharmaceutical companies worldwide based on prescription drug market share in 2019 and 2026*, Top 10 biotech and pharmaceutical companies based on market cap 2022, Leading 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2022 (in billion U.S. dollars), Pfizer's total revenue from 2006 to 2021 (in million U.S. dollars), Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars), Total sales of the Roche Group from 2006 to 2022 (in million Swiss francs), Johnson & Johnson's total sales 2005-2022, Johnson & Johnson's total sales from 2005 to 2022 (in million U.S. dollars), Projected top pharmaceutical companies based on new sales 2023, Leading pharmaceutical companies worldwide based on projected sales increase during 2023 (in billion U.S. dollars), Total global spending on pharmaceutical research and development from 2014 to 2028 (in billion U.S. dollars), Global top pharmaceutical companies based on R&D spending 2026, Global top 10 pharmaceutical companies based on projected R&D spending in 2026 (in billion U.S. dollars), Patent expiration risks for total worldwide prescription drug revenue 2020-2028, Worldwide total prescription drug revenue at risk from patent expiration from 2020 to 2028 (in billion U.S. dollars), Worldwide prescription drug revenue - market risk from patent expiration 2020-2028, Share of global prescription drug revenue at risk from patent expiration from 2020 to 2028, Pharmaceutical industry - number of new substances 1998-2021, Number of new chemical or biological entities developed between 1998 and 2021, by region of origin, Pharma companies worldwide with active R&D pipelines 2001-2022, Total number of pharmaceutical companies with active R&D pipelines worldwide from 2001 to 2022, Total number of novel drugs approved by CDER from 2008 to 2022, Projected most valuable R&D projects based on net present value 2022, Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2022 (in billion U.S. dollars), World pharmaceutical sales by region forecast 2025, Projected global pharmaceutical sales for 2025, by region* (in billion U.S. dollars), Global spending on medicines in 2010, 2021, and a forecast for 2026 (in billion U.S. dollars), CAGR by product type in pharmaceutical markets forecast 2022-2026, Projected pharmaceutical spending CAGR worldwide between 2022 and 2026, by market and product type, Country comparison in spending on medicine 2026, Projected spending on medicine of selected countries worldwide in 2026 (in billion U.S. dollars), Leading global pharmaceutical products by projected sales 2026, Projected top 10 global pharmaceutical products by sales in 2026 (in million U.S. dollars), Top global biopharma drugs by lifetime sales up to 2026, Projected top 10 pharmaceutical products worldwide based on lifetime sales as of 2026 (in billion U.S. dollars), COVID-19 vaccine dose numbers by top manufacturer 2021, Drug manufacturers with the highest number of ordered COVID-19 vaccine doses as of March 2021* (in million doses), Top companies by COVID-19 treatment vaccines in development June 2022, Leading companies by number of COVID-19 drugs and vaccines in development as of June 3, 2022, Number of COVID-19 drugs in development worldwide by phase June 2022, Number of coronavirus (COVID-19) drugs and vaccines in development worldwide as of June 3, 2022, by phase, BARDA funding for the development of COVID-19 vaccines in the U.S. 2021, BARDA funding for the development of COVID-19 vaccines in the United States as of March 2021* (in million U.S. dollars), Forecasted sales of select COVID-19 vaccines worldwide 2021-2022, Forecasted sales of select COVID-19 vaccines worldwide in 2021 and 2022 (in billion U.S. dollars), Gilead Science's remdesivir manufacturing projections 2020, Cumulative amount of remdesivir treatment courses projected to be manufactured by Gilead Sciences during 2020 (in 1,000s), Global mRNA vaccines and therapeutics market for COVID-19 Q4 2020 vs. 2025, Global mRNA vaccines and therapeutics market for COVID-19 in Q4 2020 and a forecast for Q4 2025 (in million U.S. dollars). Creditors use this ratio as an indicator to measure a companys creditworthiness. Accounts payable turnover ratio is used to measure a companys capacity of short-term liquidity. By 2025, the market is estimated to have a CAGR of 8%, reaching $1700.97 billion. The U.S. has been known to produce medicines that treat a wide range of diseases otherwise impossible to treat. if(typeof(wpDataCharts)=='undefined'){wpDataCharts = {};}; wpDataCharts[527] = {render_data: {"options":{"title":{"text":"World Pharmaceutical Sales by Region 2010-2021","floating":false,"align":"center"},"series":[{"type":"","name":"World total","color":"","label":"World total","orig_header":"worldtotal","data":[780000,799000,810000,759000,826000,906000,916000,930000,972000,1059000,1101000,1186000],"yAxis":0},{"type":"","name":"United States","color":"","label":"United States","orig_header":"unitedstates","data":[315000,329000,326000,328000,369000,416000,437000,440000,467000,493000,515000,555000],"yAxis":0},{"type":"","name":"Emerging markets","color":"","label":"Emerging markets","orig_header":"emergingmarkets","data":[152000,151000,168000,160000,168000,183000,185000,198000,199000,207000,255000,285000],"yAxis":0},{"type":"","name":"Europe","color":"","label":"Europe","orig_header":"europe","data":[181000,204000,206000,177000,179000,197000,182000,177000,192000,207000,216000,228000],"yAxis":0},{"type":"","name":"Established ROW","color":"","label":"Established ROW","orig_header":"establishedrow","data":[131000,113000,110000,94000,110000,109000,113000,112000,113000,115000,115000,118000],"yAxis":0}],"xAxis":{"categories":[2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021],"title":{"text":"Region"},"crosshair":false},"yAxis":[{"gridLineDashStyle":"solid","title":{"text":"Sales in Million US$"},"crosshair":false},[],[],[],[]],"chart":{"backgroundColor":"","borderWidth":0,"borderColor":"","borderRadius":0,"zoomType":"none","panning":false,"panKey":"shift","plotBackgroundColor":"","plotBackgroundImage":"","plotBorderColor":"","plotBorderWidth":"","inverted":false},"subtitle":{"text":"","align":"center"},"tooltip":{"enabled":true,"backgroundColor":"rgba(255,255,255,0.85)","borderWidth":"1","borderColor":"","borderRadius":3,"shared":false,"valuePrefix":"","valueSuffix":""},"legend":{"enabled":true,"backgroundColor":"","title":{"text":""},"layout":"horizontal","align":"center","verticalAlign":"bottom","borderWidth":"0","borderColor":"","borderRadius":"0"},"exporting":{"enabled":false,"chartOptions":{"plotOptions":{"series":{"dataLabels":{"enabled":false}}}},"filename":"","width":"","buttons":{"contextButton":{"align":"right","verticalAlign":"top","symbolStroke":"#666","text":""}}},"credits":{"enabled":true,"href":"https:\/\/market.us\/","text":"\u00a9 Market.us 2022"}},"type":"highcharts_basic_column_chart","height":"400"}, engine: "highcharts", type: "highcharts_basic_column_chart", title: "World Pharmaceutical Sales by Region 2010-2021", container: "wpDataChart_527", follow_filtering: 0, wpdatatable_id: 620, group_chart: 0}.